{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A First-in-Human, Phase 1a\/1b Trial to Assess the Safety, Tolerability and Preliminary Efficacy of LY4175408, an Antibody Drug Conjugate Targeting Protein Tyrosine Kinase 7-Expressing Tumor Cells, in Participants with Selected Advanced Solid Tumors","item":"https:\/\/www.regionalcancercare.org\/trials\/a-first-in-human-phase-1a-1b-trial-to-assess-the-safety-tolerability-and-preliminary-efficacy-of-ly4175408-an-antibody-drug-conjugate-targeting-protein-tyrosine-kinase-7-expressing-tumor-cells-in\/#breadcrumbitem"}]}